Highlights
A collection of news and information related to Hepatitis C published by this site and its partners.
Displaying items 1-12 of 102
» View wsbt.com items only
1
2
3
4
5
6
7
8
9
•
Next >
-
SPECIAL REPORT: Teens & Tats ... Paying the price
WSBT-TV Anchor/ReporterAs tattoos have become more mainstream in our culture, more and more teens at younger and younger ages are hitting up their parents to be inked. But there are so many considerations besides just age, including health considerations. And one of the...Tags: Diseases and Illnesses, Hepatitis, Family, Health
-
Ky. weighed politics, medicine in inmate's surgery
LOUISVILLE, Ky. (AP) — A condemned killer's fight to receive surgery for agonizing hip pain pushed Kentucky officials into an uncomfortable debate over security, politics and even the possibility of inviting scorn from Fox News pundits. Emails...
Tags: Steve Beshear, News Media, Laws, Fox News Channel (tv network), Hip Replacement
-
CDC to baby boomers: Get tested for hepatitis C
ATLANTA (AP) — For the first time, the government is proposing that all baby boomers get tested for hepatitis C. Anyone born from 1945 to 1965 should get a one-time blood test to see if they have the liver-destroying virus, the Centers for...Tags: Diseases and Illnesses, Viral Diseases and Infections, U.S. Centers for Disease Control and Prevention, Health, Liver Cancer
-
New J&J anti-depressant related to 'Special K' party drug
ReutersNEW BRUNSWICK, New Jersey (Reuters) - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a treatment for patients with depression who have failed to benefit from standard medications. The intranasal drug, called...Tags: Johnson & Johnson Inc., Topamax (drug), Litigation, Symptoms, Pharmaceuticals
-
J&J planea buscar aprobación de regulador para más de 10 nuevos fármacos al 2017
Reuters23 mayo (Reuters) - Johnson & Johnson dijo el jueves que planea pedir la aprobación de los reguladores para más de diez nuevos fármacos antes del 2017, incluidos medicamentos para tratar la hepatitis C, enfermedades al sistema inmunológico y la...Tags: Johnson & Johnson Inc., Polio, China
-
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters* Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...Tags: Novartis AG, Merck & Company Incorporated, Earnings, Patents, Copyrights and Trademarks, Parties and Movements
-
Experimental Gilead drug effective in early-stage leukemia trial
ReutersBy Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...Tags: Diseases and Illnesses, Leukemia, Medical Specialization, HIV, Symptoms
-
Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C
The Hartford CourantResearchers need to work harder to screen high-risk populations for people who are infected with both HIV and hepatitis C, say the authors of a new Yale University study on the incidence of co-infection in the New Haven area. The study, published Tuesday...Tags: Diseases and Illnesses, New Britain, Liver Disease, New Haven (New Haven, Connecticut), Waterbury
-
International consortium releases hepatitis C data
Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...Tags: Liver Disease, Food and Drug Administration, Symptoms, Liver Cancer, Colleges and Universities
-
Abbvie says Chief Scientific Officer John Leonard to retire
ReutersMay 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....Tags: Humira (drug), Chemical Industry, Pharmaceuticals, Rheumatoid Arthritis, Science and Technology
-
Muchos estadounidenses no se realizan el examen adecuado para la hepatitis C: CDC
ReutersPor Julie Steenhuysen NUEVA YORK (Reuters) - Funcionarios de salud pública de Estados Unidos informaron que sólo la mitad de la población que alguna vez estuvo infectada con el virus de la hepatitis C se realizó la prueba de detección adecuada...Tags: Diseases and Illnesses, Viral Diseases and Infections, Disease Prevention, U.S. Centers for Disease Control and Prevention
-
Many with hepatitis C don't get needed follow-up tests, CDC says
Half of all patients who have tested positive for hepatitis C have not had follow-up testing to see if they are still infected, according to the Centers for Disease Control and Prevention. That means many people are living with the disease and not...
Tags: Diseases and Illnesses, Medical Procedures and Tests, Disease Prevention, U.S. Centers for Disease Control and Prevention, Cirrhosis
May 4, 2012
|Story| WSBT-TV
May 17, 2012
|Story| AP Broadcast
May 18, 2012
|Story| AP Broadcast
May 23, 2013
|Story| Reuters
May 23, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 14, 2013
|Story| Hartford Courant
May 2, 2013
|Story| South Florida Sun-Sentinel
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Los Angeles Times
Original site for Hepatitis C topic gallery.